david ricks eli lilly - Search News

News

Eli Lilly, Weight loss and type 2 diabetes

UPI on MSN · 4h

Experimental Eli Lilly weight loss drug proves promising for type 2 diabetics

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its latest clinical testing, the Indianapolis-based drugmaker announced Thursday.

USA TODAY on MSN · 12h

Eli Lilly announces trial results of new weight loss, diabetes pill; stock booms

Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages and lowered blood sugar in patients during a clinical trial.

Insider on MSN · 14h

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen.

Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial results.

8don MSN

Eli Lilly CEO David Ricks Just Delivered Terrible News to Investors: Should You Sell the Stock?

Some industries have escaped these moves by the administration, at least for now. One of them is the pharmaceutical industry.

Fierce Pharma13d

Eli Lilly CEO on Trump's tariffs: 'It'll be hard to come back from here'

But at the same time, industry leaders are bracing for the news that they think is inevitable given Trump’s declaration in ...

Clinical Trials Arena on MSN13h

Eli Lilly’s shares up as oral GLP-1RA scores in first Phase III trial

Lilly plans to submit orforglipron for approval in weight management by the end of 2025, with a T2D application to follow in ...

Medical Marketing & Media11h

Eli Lilly’s GLP-1 pill aces late-stage trial days after Pfizer pulls theirs

The pharma giant said its oral GLP-1 drug demonstrated significant efficacy results and a safety profile consistent with its other GLP-1 products.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results